Novo Nordisk plans to invest approximately $158 million into revamping its Montes Claros manufacturing facility in Minas Gerais, Brazil, Bloomberg reported Oct. 5.
Read the full post on Becker's Hospital Review | Healthcare News & Analysis
Novo Nordisk to invest $158M in insulin plant
